CD5

CD5

CD5 詳細

Molecule Name
T-cell surface glycoprotein CD5
分子の別称
CD5,LEU1
Drug Development Progress
治験薬の数13
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Epididymis Secretory Sperm Binding Protein,CD5,Lymphocyte antigen T1/Leu-1,T-cell surface glycoprotein CD5,CD5 Molecule,CD5 Antigen (P56-62),LEU1,CD5 Antigen,T1,CD5 Antigens
バックグランド
T-cell surface glycoprotein CD5 is also known as Lymphocyte antigen T1/Leu-1 and LEU1,which is phosphorylated on tyrosine residues by LYN,so CD5 can create binding sites for PTPN6/SHP-1.CD5 may act as a receptor in regulating T-cell proliferation. CD5 is expressed at various developmental and activation stages on human B cells.CD5 is a well established negative regulator of TCR and BCR signalling.CD5-positive cells may also prevent the emergence of autoimmunity by provision of cytokines such as IL-10. Development,selection and function of different B- and T-cell subsets or their preferential survival may be directly or indirectly dependent on different glycan structures associated with CD5 or CD5-like molecules.

CD5 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CD5-targeted CAR-T cells therapy(Senlang Biotechnology)Phase 2 ClinicalHebei Senlang Biological Technology Co Ltd
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5/CD7-Specific CAR-T Cells therapy(Essen Biotech)BAH246; BAH-246; EB-BH2026Phase 2 ClinicalEssen Biotech
Central Nervous System Diseases; Leukemia, Prolymphocytic, T-Cell; Leukemia, T-Cell; Lymphoma, T-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5 CAR T Cells therapy(Beijing GoBroad Hospital)Phase 2 ClinicalBeijing GoBroad Hospital
Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
MB-105(March Biosciences)MB-105(March Biosciences)Phase 2 ClinicalMarch Biosciences Inc
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
anti-CD5 CAR T-cell therapy (Beijing Boren Hospital)Phase 1 ClinicalBeijing Gao Boren Hospital Co Ltd
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5CARCD5CARPhase 1 ClinicaliCell Gene Therapeutics LLC
Lymphoma, Non-Hodgkin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CT-125ACT-125A; RD-125Phase 1 ClinicalNanjing Iaso Biotherapeutics Co Ltd
Hematologic Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Plasmablastic Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5 Targeting Chimeric Antigen Receptor NK Cells (CAR-NK) thrapy(Precision Biotechnology)Phase 1 ClinicalChongqing Precision Biotechnology Co Ltd
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5 CAR T-cells therapy(Yake Biotechnology)Phase 1 ClinicalShanghai YaKe Biotechnology Co Ltd
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
AB-205 (Artiva Biotherapeutics/GC Cell)CD5 CAR-NK; GCC-2005; GL-205; GCC2005Phase 1 ClinicalGC Cell Corp
Lymphoma, T-Cell
詳細
Autologous CAR-T cell therapy(Vittoria Biotherapeutics)VIPER-101; Senza5 CART5; VIPER101Phase 1 ClinicalVittoria Biotherapeutics Inc
Lymphoma, T-Cell
詳細
CD5 CAR T-Cells (Baylor College of Medicine)Phase 1 ClinicalBaylor College Of Medicine
Lymphoma, Non-Hodgkin; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細
CD5 CAR-T Therapy(Xuanwu Hospital)Phase 1 ClinicalXuanwu Hospital Of Capital Medical University
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
詳細